Page last updated: 2024-12-07

6-sulfanilamidoindazole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

6-sulfanilamidoindazole: induces acute arthritis & periarticular inflammation in rats [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID83696
SCHEMBL ID1143141
MeSH IDM0053957

Synonyms (27)

Synonym
4-amino-n-(1h-indazol-6-yl)benzenesulfonamide
nsc-140721
nsc140721
6-(p-aminobenzenesulfonylamino)indazole
benzenesulfonamide, 4-amino-n-1h-indazol-6-yl-
13744-68-8
sulfanilamide, n1-1h-indazol-6-yl-
6-(sulfanilamido)indazole
n-(indazol-6-yl)-4-aminobenzenesulphonamide
einecs 237-314-4
6-sulfanilamidoindazole
nsc 140721
OPREA1_722588
n1-(6-indazolyl)sulfanilamide, 98%
inchi=1/c13h12n4o2s/c14-10-2-5-12(6-3-10)20(18,19)17-11-4-1-9-8-15-16-13(9)7-11/h1-8,17h,14h2,(h,15,16
AKOS003244140
1h-indazol-6-yl[(4-aminophenyl)sulfonyl]amine
benzenesulfonamide,4-amino-n-1h-indazol-6-yl-
FT-0636954
n1-(6-indazolyl)sulfanilamide
RLNLIVBLEZDLMZ-UHFFFAOYSA-N
4-amino-n-(1h-indazol-6-yl)-benzenesulfonamide
SCHEMBL1143141
DTXSID50160183
J-007023
3-amino-3-(3,5-dichloro-4-hydroxy-phenyl)-propionicacid
4-amino-n-(1h-indazol-6-yl)benzene-1-sulfonamide

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Endotoxin in a dosage of 3,000 microgram was not lethal for nonmedicated control animals."( Endotoxin toxicity in rats with 6-sulfanilamidoindazole arthritis.
Hiramoto, RN; Miller, ML; Samuelson, CO; Ward, JR, 1979
)
0.54
"Hexobarbital sleeping time was prolonged and ethylmorphine N-demethylation was inhibited after a single dosage or seven administration of 6-SAI to old rats."( Drug metabolism in rats with arthritis induced by 6-sulfanilamidoindazole (6-SAI).
Hirschelmann, R; Müller, D, 1981
)
0.52
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (75.00)18.7374
1990's1 (8.33)18.2507
2000's2 (16.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.67

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.67 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index4.38 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.67)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]